Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan

Int J Urol. 2024 Jun;31(6):696-698. doi: 10.1111/iju.15435. Epub 2024 Feb 29.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal* / therapeutic use
  • Carcinoma, Transitional Cell* / drug therapy
  • Carcinoma, Transitional Cell* / pathology
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / pathology

Substances

  • Antibodies, Monoclonal
  • enfortumab vedotin